Can testosterone increase blood pressure? A practical guide to TRT and blood pressure for men

Yes, testosterone can increase blood pressure in some men, but the average effect is usually small and the research is mixed. The bigger issue is identifying who is most likely to see a rise, then monitoring blood pressure and lab markers so treatment stays safe.

Key takeaways

• In published studies, the effect of testosterone replacement therapy and blood pressure is inconsistent. Some trials show small increases, while a 2024 study in World Journal of Men’s Health linked TRT to lower blood pressure in men with low testosterone.^[1]
• Men with obesity or higher baseline hematocrit are more likely to see blood pressure rise on TRT in a 2024 randomized controlled trial in Hypertension.
• Testosterone deficiency is diagnosed with symptoms plus consistently low morning testosterone on repeat testing, and guideline cut points vary. The American Urological Association (AUA) uses a total testosterone level of about 300 ng/dL as a diagnostic threshold, while some clinicians treat 300 to 350 ng/dL as “borderline” and use free testosterone and clinical context to guide further evaluation and treatment decisions.
• Home monitoring works best when you sit quietly for 5 minutes, keep both feet on the floor, take 2 readings one minute apart, and log results daily.
• For blood pressure support, targets used in hypertension care include 150 minutes per week of moderate activity, at least 7 hours of sleep, and whole food eating patterns such as DASH or Mediterranean style diets.

The relationship between testosterone and blood pressure in men

Can testosterone increase blood pressure? Yes, it can, especially in certain higher risk men, but it does not raise blood pressure in every man and it does not automatically mean you will develop hypertension.^[3]

According to a 2024 study in World Journal of Men’s Health, testosterone replacement therapy was associated with lower blood pressure in more than 700 men treated for low testosterone.^[1] Other research, including randomized trials, has shown small increases in blood pressure with some testosterone formulations or in certain subgroups, which is why you will see clinicians treat this as an individualized risk question, not a universal side effect.^[3]

It is also worth zooming out. Research linking low testosterone to central obesity, metabolic syndrome, and type 2 diabetes matters because those conditions raise long term cardiovascular risk in men.^,[2] In other words, avoiding testosterone treatment does not automatically mean you are avoiding cardiovascular risk. It may mean you are leaving a different risk factor unmanaged.

How testosterone therapy can shift blood pressure

Red blood cells, hematocrit, and thicker blood

Testosterone stimulates red blood cell production.^[4] Hematocrit is the percent of your blood made up of red blood cells. When hematocrit rises too high, blood can become more viscous, meaning thicker and slower flowing, which can push blood pressure up.^[4]

Secondary polycythemia is an abnormally high red blood cell concentration caused by a trigger such as testosterone therapy. It is a known risk on TRT, and it is one of the most practical reasons clinicians track hematocrit during treatment.^[4]

Fluid retention and higher blood volume

Water retention is a possible side effect of TRT, and retaining fluid can raise blood volume, which increases pressure on vessel walls and may raise blood pressure. Extracellular water is the fluid outside your cells, and some clinical studies have shown testosterone can increase it in certain men.

This mechanism is also why clinicians take reports of sudden weight gain or swelling seriously during dose changes or early in therapy. Fluid shifts are not always dangerous, but they can be a signal to reassess.

Blood vessel tone, dilation, and flow

Testosterone is not only a sex hormone. It also acts on the cardiovascular system, including effects on blood vessel dilation and blood flow. Vasodilation is the widening of blood vessels, which can lower resistance and support healthier blood pressure, but these effects can vary with dose, formulation, and a man’s underlying vascular health.

This mixed physiology is one reason different studies can produce different blood pressure findings. Testosterone can influence several levers at once, and not all men start from the same baseline.

Kidney support, salt balance, and who is at higher risk

Testosterone may support proper kidney function, and the kidneys help regulate the body’s salt and water balance, which is a major driver of blood pressure control. This does not mean TRT is a blood pressure medication. It means the system it touches is connected to blood pressure regulation.

According to a 2024 randomized controlled trial in Hypertension, blood pressure responses to testosterone therapy were amplified by hematocrit levels, and men with obesity or higher baseline hematocrit were more likely to experience blood pressure increases on therapy. This is the clinical takeaway. The question is not only, “does TRT raise blood pressure?” The more useful question is, “am I the type of patient who is more likely to see a rise?”

Clinical thresholds used in practice: Testosterone deficiency is not diagnosed from one lab value alone. The AUA guideline uses total testosterone around 300 ng/dL (with symptoms) as a diagnostic cut point and recommends repeat morning testing, while free testosterone may be considered in selected men (for example, when total testosterone is borderline and symptoms persist). Some clinics use higher “clinical discussion” thresholds (such as 300 to 350 ng/dL) to prompt further evaluation, but diagnosis and treatment decisions should still follow a guideline based workup and shared decision making.

Conditions that change your risk on TRT

If you are searching “testosterone replacement therapy and blood pressure,” you are usually trying to figure out personal risk. These conditions can shift that risk in men because they change baseline blood pressure, fluid balance, or how your body responds to testosterone.

• Central obesity: Fat gain around the abdomen that is strongly linked to metabolic risk in men, and it is associated with low testosterone in observational data.
• Metabolic syndrome: A cluster of risk factors including abdominal obesity and impaired glucose metabolism that raises cardiovascular risk. It is commonly discussed alongside low testosterone in men.^[2]
• Type 2 diabetes: A metabolic disease linked with higher cardiovascular risk, and low testosterone is commonly found in men with this condition in clinical studies.
• High baseline hematocrit: A lab pattern that can amplify blood pressure increases on TRT in trial data, and it also predicts higher likelihood of TRT related erythrocytosis in clinical practice.^,[4]
• Opioid induced androgen deficiency: Low testosterone related to chronic opioid exposure, which has been specifically studied in randomized trials assessing hematocrit and blood pressure responses during TRT.

Limitations note: The evidence is mixed because studies differ by testosterone formulation, dose, trial design, and patient population. Observational studies can show association but cannot prove cause. Randomized trials are stronger, but they may not reflect every real world patient, especially men with multiple comorbidities.

Symptoms and signals to watch while on TRT

Blood pressure changes are often silent. That is why numbers beat guesswork. Still, men on TRT should pay attention to patterns that can point to fluid retention, rising hematocrit, or loss of blood pressure control.

• Home blood pressure trend drifting upward: For example, a change from 114/70 to 117/70 is a measurable increase, but it is still not automatically hypertension. The trend matters more than one reading.^[3]
• New swelling in ankles or lower legs: This can signal fluid retention, especially if it shows up after starting or increasing a dose.
• Rapid, unexplained scale weight gain: A possible clue for water retention rather than fat gain.
• Lab report shows rising hematocrit: Hematocrit is a tracked safety marker on TRT because secondary polycythemia can raise blood pressure risk.^[4]
• Existing hypertension getting harder to control: If your usual plan stops working, it is a reason to review your TRT protocol and overall cardiovascular strategy with a clinician.

What to do about it

The safest way to handle the question “can testosterone increase blood pressure” is to plan for monitoring from day one. That includes confirming you actually have clinically meaningful testosterone deficiency, choosing the right therapy for your goals, and tracking the markers that predict blood pressure shifts.

According to urology best practice principles reflected in major guidelines, men on testosterone therapy should have cardiovascular risk assessed, blood pressure controlled, and follow up labs including hematocrit, lipids, and overall cardiovascular status.

1. Step 1: Confirm the diagnosis and your baseline risk: Get repeat morning testosterone testing and a full workup before treatment. Definition: luteinizing hormone (LH) is a pituitary signal that tells the testes to produce testosterone. LH and follicle stimulating hormone (FSH) help clinicians distinguish primary hypogonadism (testicular dysfunction, often with higher LH/FSH) from secondary hypogonadism (pituitary or hypothalamic causes, often with low or inappropriately normal LH/FSH). Treatment should be individualized by an endocrinologist or urologist based on that pattern, symptom burden, fertility goals, and comorbidities. In men with secondary hypogonadism who want to preserve testicular function, clinicians sometimes use off label medications that stimulate endogenous testosterone production (for example, selective estrogen receptor modulators such as clomiphene citrate; enclomiphene is not approved for male hypogonadism in many regions). When testosterone replacement is indicated, options include clinician directed TRT with an individualized formulation and dose. Ask your clinician about comprehensive baseline labs (for example CBC/hematocrit, metabolic and lipid markers, and other guideline based tests) so decisions are based on overall risk, not a single testosterone number.
2. Step 2: Build a blood pressure friendly foundation before and during treatment: Practical, guideline consistent advice is simple. Manage high blood pressure before starting TRT when possible, and use lifestyle levers that reliably reduce blood pressure. Aim for 150 minutes per week of moderate intensity aerobic activity such as brisk walking, swimming, biking, dancing, or jogging, or 75 minutes per week of higher intensity training. Prioritize whole foods with DASH or Mediterranean style patterns that limit high sodium foods. Treat sleep as a blood pressure intervention and target at least 7 hours nightly because chronic short sleep is linked to higher blood pressure in men. If stress is high, use practical stress reduction like scheduling, mindfulness, and reducing avoidable triggers, since stress hormones can increase heart rate and constrict blood vessels over time.
3. Step 3: Monitor like it is part of the prescription: Use an at home cuff style monitor, since cuff style devices are typically more accurate than wrist devices. Measure at the same time each day. Sit upright with feet on the floor and your arm supported. Rest for 5 minutes. Take 2 readings one minute apart. Log results so you and your clinician can spot trends. Pair blood pressure tracking with lab monitoring, especially hematocrit, since erythrocytosis and secondary polycythemia are key safety concerns linked to blood pressure changes on TRT.^[4] If you use a local clinic or telehealth service, make sure it includes ongoing follow up, clear lab monitoring intervals, and dose adjustments based on symptoms and safety markers.

For some men, supplements are also part of the conversation. A 2021 systematic review of 49 clinical trials found that magnesium at 600 mg per day or more could lower blood pressure, but it can cause diarrhea, nausea, and cramping, and it can interact with common medications such as certain antibiotics, proton pump inhibitors, diuretics, and osteoporosis drugs. Discuss it with your clinician before starting.

Myth vs fact

• Myth:
  “TRT always causes high blood pressure.”
  Fact: Studies are mixed. Some show small increases, others show no link, and at least one large 2024 cohort found lower blood pressure on TRT in hypogonadal men.^[1]
• Myth:
  “If my systolic number goes up a few points, I have hypertension.”
  Fact: A small rise is not the same as developing hypertension. Trends over time and your overall risk profile matter.^[3]
• Myth:
  “If I feel fine, my blood pressure is fine.”
  Fact: Blood pressure changes are often silent. Home monitoring is more reliable than symptoms.
• Myth:
  “High hematocrit is just a lab quirk.”
  Fact: Higher hematocrit can thicken blood and is linked to stronger blood pressure responses on TRT in trial data. It is a core safety marker for men on therapy.^,[4]
• Myth:
  “The only option is injections forever.”
  Fact: Treatment depends on the cause of low testosterone and your goals. In selected men with secondary hypogonadism who wish to preserve testicular function, an endocrinologist or urologist may consider off label options that stimulate endogenous production (for example clomiphene citrate, or in some settings enclomiphene, and/or hCG). When TRT is indicated, formulation and dosing can be individualized with proper monitoring.

Bottom line

Testosterone replacement therapy and blood pressure have a real connection, but it is not a one size fits all side effect. The best evidence suggests some men experience small blood pressure increases, some see no change, and some may even see improvement, with higher risk in men with obesity or higher baseline hematocrit. If you are considering TRT, confirm a true deficiency, choose the right therapy for your goals, and monitor blood pressure and hematocrit consistently with a clinician.

References

1. Hackett G, Mann A, Haider A, et al. Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men. The world journal of men’s health. 2024;42:749-761. PMID: 38449452
2. Muraleedharan V, Jones TH. Testosterone and the metabolic syndrome. Therapeutic advances in endocrinology and metabolism. 2010;1:207-23. PMID: 23148165
3. White WB, Bernstein JS, Rittmaster R, et al. Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men. Journal of clinical hypertension (Greenwich, Conn.). 2021;23:1420-1430. PMID: 34114726
4. Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis Following Testosterone Therapy. Sexual medicine reviews. 2018;6:77-85. PMID: 28526632